Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helfand

Showing results (401-410 of 657) with videos related to

Pageof 66
Sort By:
Biochemistry|June 28, 2007
Raman crystallographic studies of the intermediates formed by Ser130Gly SHV, a beta-lactamase that confers resistance to clinical inhibitorsMarion S Helfand, Magdalena A Taracila, Monica A Totir, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|August 21, 2021
Harmonization of Four Delirium Instruments: Creating Crosswalks and the Delirium Item-Bank (DEL-IB)Benjamin K I Helfand, Elke Detroyer, Koen Milisen, et al.
Sexual Medicine|October 16, 2015
A Longitudinal Study of Predictors of Sexual Dysfunction in Men on Active Surveillance for Prostate CancerShane M Pearce, Chi-Hsiung E Wang, David E Victorson, et al.
The Prostate|June 30, 2009
Common variants in 8q24 are associated with risk for prostate cancer and tumor aggressiveness in men of European ancestryProdipto Pal, Huifeng Xi, Saurav Guha, et al.
The Journal of Biological Chemistry|August 2, 2005
High resolution crystal structures of the trans-enamine intermediates formed by sulbactam and clavulanic acid and E166A SHV-1 {beta}-lactamasePius S Padayatti, Marion S Helfand, Monica A Totir, et al.
The Journal of Urology|December 19, 2012
Personalized prostate specific antigen testing using genetic variants may reduce unnecessary prostate biopsiesBrian T Helfand, Stacy Loeb, Qiaoyan Hu, et al.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 1, 1996
Immune activation, allergic drug toxicity and mortality in HIV-positive tuberculosisR S Wallis, M S Helfand, C C Whalen, et al.
Translational Oncology|April 2, 2013
Imatinib and Dasatinib Inhibit Hemangiosarcoma and Implicate PDGFR-β and Src in Tumor GrowthErin B Dickerson, Kevin Marley, Wade Edris, et al.
Journal of General Internal Medicine|May 10, 2018
Rapid Evidence Review of Mobile Applications for Self-management of DiabetesStephanie Veazie, Kara Winchell, Jennifer Gilbert, et al.
Oncogene|March 7, 2023
TRIM28 promotes luminal cell plasticity in a mouse model of prostate cancerAshutosh S Yende, Emily C Williams, Andrew Pletcher, et al.
Pageof 66

Showing results (401-410 of 657) with videos related to

Sort By:
Pageof 66
Biochemistry|June 28, 2007
Raman crystallographic studies of the intermediates formed by Ser130Gly SHV, a beta-lactamase that confers resistance to clinical inhibitorsMarion S Helfand, Magdalena A Taracila, Monica A Totir, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|August 21, 2021
Harmonization of Four Delirium Instruments: Creating Crosswalks and the Delirium Item-Bank (DEL-IB)Benjamin K I Helfand, Elke Detroyer, Koen Milisen, et al.
Sexual Medicine|October 16, 2015
A Longitudinal Study of Predictors of Sexual Dysfunction in Men on Active Surveillance for Prostate CancerShane M Pearce, Chi-Hsiung E Wang, David E Victorson, et al.
The Prostate|June 30, 2009
Common variants in 8q24 are associated with risk for prostate cancer and tumor aggressiveness in men of European ancestryProdipto Pal, Huifeng Xi, Saurav Guha, et al.
The Journal of Biological Chemistry|August 2, 2005
High resolution crystal structures of the trans-enamine intermediates formed by sulbactam and clavulanic acid and E166A SHV-1 {beta}-lactamasePius S Padayatti, Marion S Helfand, Monica A Totir, et al.
The Journal of Urology|December 19, 2012
Personalized prostate specific antigen testing using genetic variants may reduce unnecessary prostate biopsiesBrian T Helfand, Stacy Loeb, Qiaoyan Hu, et al.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 1, 1996
Immune activation, allergic drug toxicity and mortality in HIV-positive tuberculosisR S Wallis, M S Helfand, C C Whalen, et al.
Translational Oncology|April 2, 2013
Imatinib and Dasatinib Inhibit Hemangiosarcoma and Implicate PDGFR-β and Src in Tumor GrowthErin B Dickerson, Kevin Marley, Wade Edris, et al.
Journal of General Internal Medicine|May 10, 2018
Rapid Evidence Review of Mobile Applications for Self-management of DiabetesStephanie Veazie, Kara Winchell, Jennifer Gilbert, et al.
Oncogene|March 7, 2023
TRIM28 promotes luminal cell plasticity in a mouse model of prostate cancerAshutosh S Yende, Emily C Williams, Andrew Pletcher, et al.
Pageof 66